top of page
Agenda
7:30-8:30 AM
8:30-9:00 AM
9:00-10:00 AM
10:00-10:15 AM
10:15-11:30 AM
11:30-12:30 PM
12:30-2:00 PM
2:00-2:15 PM
2:15-3:30 PM
3:30-4:30 PM
4:30-5:00 PM
5:00-6:30 PM
Registration & Breakfast
Opening Remarks
1st Keynote Speaker
Morning Coffee Break
Morning Breakout Sessions
Lunch & Networking
Executive Panel
Afternoon Coffee Break
Afternoon Breakout Sessions
2nd Keynote Speaker
Closing Remarks
Reception
A Closer Look Into Our
8 Breakout Sessions
(May be subject to change)
Morning Session
Breakout Session 1
The Second Trump Administration’s Healthcare Agenda: What’s Next?
Description: As the second Trump administration begins, this panel will examine key healthcare policy shifts, including changes to the ACA, Medicaid, and Medicare, drug pricing transparency, and healthcare innovation. Panelists will also discuss the evolving roles of HHS, CMS, and the FDA, exploring the implications for health equity, healthcare organizations, and the broader system.
Breakout Session 2
Confronting the Obesity Epidemic: Transforming America’s Health
Description: With obesity rates continuing to rise, the U.S. faces a pressing public health challenge with far-reaching consequences. This session examines innovative approaches to addressing the epidemic, including AI-driven personalized interventions, public health campaigns, and community-based initiatives.
Breakout Session 3
Transforming Healthcare Operations: AI in the Workplace and Workforce Dynamics
Description: AI is reshaping the healthcare workplace by streamlining operations, enhancing decision-making, and augmenting employee capabilities. This session explores how AI tools are improving administrative efficiency, supporting clinicians, and redefining workforce roles, while addressing challenges like job displacement, upskilling, and ethical considerations in automation.
Breakout Session 4
AI for Mental Health Support and Care: Meeting the Needs of a Growing Crisis
Description: The mental health crisis demands scalable solutions, and AI offers new opportunities for care delivery. This session focuses on AI-enabled tools like chatbots, personalized treatment plans, and early detection systems, while addressing concerns around ethics and patient trust.
Afternoon Session
Breakout Session 5
Vaccine Policy, Implementation, and Research: Shaping the Future of Public Health
Description: This panel will delve into the latest advancements in vaccine policy, implementation strategies, and research. Experts will explore how emerging scientific developments are informing vaccine policy decisions and influencing public health initiatives. A key focus will be the ongoing challenge of vaccine hesitancy versus acceptance, examining the factors driving public attitudes toward vaccines and how policy can help bridge the gap.
Breakout Session 6
Scaling Solutions in Public Health through AI: Tackling Developing Global Challenges
Description: AI holds the promise to address pressing public health challenges, from disease modeling to healthcare accessibility. This session explores how AI-driven insights can guide policymaking, and improve resource allocation, while examining the challenges and opportunities of implementing these solutions. Experts will also discuss AI’s potential to facilitate data sharing and communication in the changing landscape of public health.
Breakout Session 7
Patient Privacy in the Digital Health Era: Protecting Data in an AI-Driven World
Description: As AI becomes integral to digital health and medical research, safeguarding patient privacy has never been more critical. This session explores compliance with HIPAA, best practices for secure data-sharing partnerships, and protecting patient information in research contexts. It also highlights innovative strategies to ensure privacy while enabling technological progress in healthcare and research.
Breakout Session 8
AI-Driven Innovation in Life Sciences and Biotech: Transforming Research, Medicine, and Investment
Description: Artificial intelligence is revolutionizing life sciences, driving breakthroughs in precision medicine, pharmaceutical R&D, and biotech innovation. This session will explore how AI accelerates drug discovery, enhances clinical trial efficiency, and enables individualized treatment plans through advancements in genomics, predictive analytics, and disease modeling. Additionally, we will examine the role of AI in shaping investment strategies, optimizing costs, and expanding patient access to cutting-edge therapies. Join leading experts as they discuss the intersection of AI, biomedical research, and the evolving landscape of healthcare innovation.
YHC Conference Book Coming Soon
bottom of page